Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
US Army
AstraZeneca
Cerilliant
Daiichi Sankyo
Baxter
UBS
McKesson

Generated: November 18, 2018

DrugPatentWatch Database Preview

IFOSFAMIDE; MESNA - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ifosfamide; mesna and what is the scope of ifosfamide; mesna freedom to operate?

Ifosfamide; mesna is the generic ingredient in two branded drugs marketed by Baxter Hlthcare and Teva Pharms Usa, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ifosfamide; mesna. One supplier is listed for this compound.

Summary for IFOSFAMIDE; MESNA
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 5
Suppliers / Packagers: 1
Clinical Trials: 373
DailyMed Link:IFOSFAMIDE; MESNA at DailyMed
Pharmacology for IFOSFAMIDE; MESNA
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity

US Patents and Regulatory Information for IFOSFAMIDE; MESNA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-004 Oct 10, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa IFOSFAMIDE/MESNA KIT ifosfamide; mesna INJECTABLE;INTRAVENOUS 075874-001 Feb 26, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa IFOSFAMIDE/MESNA KIT ifosfamide; mesna INJECTABLE;INTRAVENOUS 075874-002 Feb 26, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-003 Oct 10, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for IFOSFAMIDE; MESNA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-003 Oct 10, 1992 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-004 Oct 10, 1992 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-004 Oct 10, 1992 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare IFEX/MESNEX KIT ifosfamide; mesna INJECTABLE;INJECTION 019763-003 Oct 10, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
US Army
AstraZeneca
Cerilliant
Daiichi Sankyo
Baxter
UBS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.